Latent builds a Clinical Reasoning Engine that reasons over patient data, interprets drug criteria, extracts key evidence, and orchestrates workflows across EHRs, payers, pharmacies, and patients to close the gap between diagnosis and treatment. The company began with prior authorization workflows and has expanded the engine across multiple processes where clinical knowledge must be translated into action. Latent serves more than 2 million patients annually and partners with over 45 health systems, including customers that represent 50% of the top 20 U.S. health systems. The company reports reducing denials by over 30% and enabling clinicians to serve twice as many patients. Latent plans to broaden its health system footprint, deepen platform integrations, invest in reliability and trust for healthcare operations, and scale its team. Founded by Sriram Somasundaram and Rishabh Jain and headquartered in San Francisco, Latent has raised $80M in total funding from investors including Transformation Capital, Spark Capital, McKesson Ventures, Conviction, General Catalyst, and Y Combinator.

Total raised

$80M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2026